As many conferences and events are cancelled or postponed, due to the COVID-19 pandemic, we catch up with the Land O’Lakes organizing committee to reveal the current session plans for this years’ meeting.
In this interview Sanyogitta Puri, Associate Director (AstraZeneca, Cambridge, UK), explores AstraZeneca’s involvement in the cell and gene therapy field.
The AAPS PharmSci360 conference was held in San Antonio (TX, USA) from 3–6 November 2019. The Bioanalysis and Bioanalysis Zone team both attended and, in this report, share their key highlights from the conference.
Scientists came together at the inaugural AAPS workshop, Opportunities and Challenges in Translating Cell and Gene Therapy Products (4—5 September, London, UK) to to discuss cell and gene therapy pipelines across different disease areas and highlight recent breakthroughs in technology and approach.